# A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers

> **NCT01119677** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 120 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Avonex

## Key facts

- **NCT ID:** NCT01119677
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-05
- **Primary completion:** 2010-10-23
- **Final completion:** 2010-10-23
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119677, "A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01119677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*